New Immunotherapy Study Findings Have Been Reported from Memorial Sloan-Kettering Cancer Center (Clinical Benefit From Immunotherapy In Patients With Sclc Is Associated With Tumor Capacity for Antigen Presentation)

Press/Media

Period	24 Oct 2023

Media coverage

Title	New Immunotherapy Study Findings Have Been Reported from Memorial Sloan-Kettering Cancer Center (Clinical Benefit From Immunotherapy In Patients With Sclc Is Associated With Tumor Capacity for Antigen Presentation)
Media name/outlet	Immunotherapy Daily
Country/Territory	United States
Date	24/10/23
Persons	Triparna Sen